Gujarat Alkalies & Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 27, 2025, 12:53 am

Market Cap	4,575 Cr.
Current Price	623
High / Low	900/484
Stock P/E
Book Value	842
Dividend Yield	0.00 %
ROCE	3.83 %
ROE	3.88 %
Face Value	10.0
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Gujarat Alkalies & Chemicals Ltd

Competitors of Gujarat Alkalies & Chemicals Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Caprolactam Chemicals Ltd	20.8 Cr.	45.2	65.0/38.2		11.6	0.00 %	6.86 %	3.67 %	10.0
Standard Industries Ltd	130 Cr.	20.2	39.0/17.5	140	20.1	5.19 %	6.83 %	6.28 %	5.00
Gujarat Alkalies & Chemicals Ltd	4,575 Cr.	623	900/484		842	0.00 %	3.83 %	3.88 %	10.0
GHCL Ltd	5,740 Cr.	600	779/472	9.59	331	2.00 %	20.6 %	17.3 %	10.0
Tata Chemicals Ltd	21,055 Cr.	826	1,247/756	43.2	871	1.81 %	7.81 %	2.32 %	10.0
Industry Average	6,525.80 Cr	483.40		64.00	392.45	1.53%	9.52%	6.89%	9.17

All Competitor Stocks of Gujarat Alkalies & Chemicals Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	1,075	1,141	1,128	1,127	1,123	1,138	913	971	921	1,002	977	991	1,029
Expenses	709	792	778	969	885	936	882	955	941	998	923	945	951
Operating Profit	366	349	351	159	238	202	31	16	-20	4	54	46	78
OPM %	34%	31%	31%	14%	21%	18%	3%	2%	-2%	0%	6%	5%	8%
Other Income	3	7	6	22	6	8	12	71	5	3	3	49	15
Interest	1	1	2	3	8	8	10	11	11	12	11	11	10
Depreciation	50	52	50	60	79	88	89	95	96	97	97	100	98
Profit before tax	317	303	305	118	157	115	-57	-18	-123	-102	-50	-16	-15
Tax %	37%	27%	37%	49%	44%	38%	0%	-0%	-6%	-55%	-11%	15%	-27%
Net Profit	201	221	191	61	87	71	-57	-18	-115	-46	-45	-18	-11
EPS in Rs	27.42	30.05	25.99	8.24	11.87	9.67	-7.78	-2.50	-15.68	-6.29	-6.06	-2.48	-1.53

Last Updated: February 28, 2025, 7:40 pm

Below is a detailed analysis of the quarterly data for Gujarat Alkalies & Chemicals Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 1,029.00 Cr.. The value appears strong and on an upward trend. It has increased from 991.00 Cr. (Sep 2024) to 1,029.00 Cr., marking an increase of 38.00 Cr..
For Expenses, as of Dec 2024, the value is 951.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 945.00 Cr. (Sep 2024) to 951.00 Cr., marking an increase of 6.00 Cr..
For Operating Profit, as of Dec 2024, the value is 78.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Sep 2024) to 78.00 Cr., marking an increase of 32.00 Cr..
For OPM %, as of Dec 2024, the value is 8.00%. The value appears strong and on an upward trend. It has increased from 5.00% (Sep 2024) to 8.00%, marking an increase of 3.00%.
For Other Income, as of Dec 2024, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Sep 2024) to 15.00 Cr., marking a decrease of 34.00 Cr..
For Interest, as of Dec 2024, the value is 10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.00 Cr. (Sep 2024) to 10.00 Cr., marking a decrease of 1.00 Cr..
For Depreciation, as of Dec 2024, the value is 98.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 100.00 Cr. (Sep 2024) to 98.00 Cr., marking a decrease of 2.00 Cr..
For Profit before tax, as of Dec 2024, the value is -15.00 Cr.. The value appears strong and on an upward trend. It has increased from -16.00 Cr. (Sep 2024) to -15.00 Cr., marking an increase of 1.00 Cr..
For Tax %, as of Dec 2024, the value is -27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 15.00% (Sep 2024) to -27.00%, marking a decrease of 42.00%.
For Net Profit, as of Dec 2024, the value is -11.00 Cr.. The value appears strong and on an upward trend. It has increased from -18.00 Cr. (Sep 2024) to -11.00 Cr., marking an increase of 7.00 Cr..
For EPS in Rs, as of Dec 2024, the value is -1.53. The value appears strong and on an upward trend. It has increased from -2.48 (Sep 2024) to -1.53, marking an increase of 0.95.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:08 pm

Metric	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	1,995	2,070	2,455	3,161	2,725	2,429	3,759	4,516	3,807	3,999
Expenses	1,660	1,622	1,669	2,046	2,148	2,072	2,774	3,568	3,775	3,817
Operating Profit	335	448	786	1,115	577	357	984	949	32	182
OPM %	17%	22%	32%	35%	21%	15%	26%	21%	1%	5%
Other Income	45	56	106	62	90	67	46	42	90	70
Interest	10	13	15	21	14	15	6	19	45	44
Depreciation	107	111	127	140	162	174	198	276	377	392
Profit before tax	262	381	749	1,016	491	235	826	695	-300	-184
Tax %	16%	19%	29%	32%	32%	29%	32%	41%	-21%
Net Profit	220	307	534	690	332	166	560	410	-237	-120
EPS in Rs	29.90	41.85	72.78	93.98	45.22	22.57	76.22	55.78	-32.25	-16.36
Dividend Payout %	15%	12%	9%	9%	18%	35%	13%	42%	-43%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	39.55%	73.94%	29.21%	-51.88%	-50.00%	237.35%	-26.79%	-157.80%
Change in YoY Net Profit Growth (%)	0.00%	34.40%	-44.73%	-81.10%	1.88%	287.35%	-264.14%	-131.02%

Gujarat Alkalies & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2016-2017 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	4%
3 Years:	16%
TTM:	1%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	0%

Stock Price CAGR
10 Years:	14%
5 Years:	11%
3 Years:	-14%
1 Year:	-23%

Return on Equity
10 Years:	%
5 Years:	5%
3 Years:	4%
Last Year:	-4%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 11:38 pm

Month	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	73	73	73	73	73	73	73	73	73	73
Reserves	2,854	3,282	3,748	4,222	4,522	5,301	5,826	6,066	6,002	6,112
Borrowings	295	353	291	247	205	498	594	597	544	603
Other Liabilities	671	726	859	988	1,090	1,282	1,484	1,599	1,404	1,625
Total Liabilities	3,894	4,435	4,970	5,531	5,891	7,154	7,977	8,335	8,023	8,413
Fixed Assets	1,821	2,073	2,104	2,300	2,610	2,587	2,702	4,250	4,617	4,491
CWIP	83	151	252	307	445	1,109	1,787	544	95	157
Investments	854	1,016	1,145	1,065	1,242	2,092	2,110	1,831	2,093	2,377
Other Assets	1,136	1,196	1,469	1,858	1,594	1,366	1,379	1,710	1,218	1,388
Total Assets	3,894	4,435	4,970	5,531	5,891	7,154	7,977	8,335	8,023	8,413

Below is a detailed analysis of the balance sheet data for Gujarat Alkalies & Chemicals Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹73.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 73.00 Cr..
For Reserves, as of Sep 2024, the value is ₹6,112.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,002.00 Cr. (Mar 2024) to ₹6,112.00 Cr., marking an increase of 110.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹603.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 544.00 Cr. (Mar 2024) to ₹603.00 Cr., marking an increase of 59.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹1,625.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,404.00 Cr. (Mar 2024) to ₹1,625.00 Cr., marking an increase of 221.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹8,413.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,023.00 Cr. (Mar 2024) to ₹8,413.00 Cr., marking an increase of 390.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹4,491.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,617.00 Cr. (Mar 2024) to ₹4,491.00 Cr., marking a decrease of 126.00 Cr..
For CWIP, as of Sep 2024, the value is ₹157.00 Cr.. The value appears strong and on an upward trend. It has increased from 95.00 Cr. (Mar 2024) to ₹157.00 Cr., marking an increase of 62.00 Cr..
For Investments, as of Sep 2024, the value is ₹2,377.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,093.00 Cr. (Mar 2024) to ₹2,377.00 Cr., marking an increase of 284.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹1,388.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,218.00 Cr. (Mar 2024) to ₹1,388.00 Cr., marking an increase of 170.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹8,413.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,023.00 Cr. (Mar 2024) to ₹8,413.00 Cr., marking an increase of 390.00 Cr..

Notably, the Reserves (6,112.00 Cr.) exceed the Borrowings (603.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	201	502	514	838	630	421	735	960	67
Cash from Investing Activity +	-352	-467	-395	-581	-634	-334	-804	-662	-90
Cash from Financing Activity +	84	13	-116	-136	-146	226	12	-140	-277
Net Cash Flow	-67	49	3	122	-150	313	-58	158	-301

Free Cash Flow

Month	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	40.00	95.00	495.00	-246.00	372.00	-141.00	390.00	352.00	-512.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	60	58	60	56	50	43	29	23	17
Inventory Days	99	94	147	99	92	88	101	111	93
Days Payable	99	125	154	134	126	111	101	119	86
Cash Conversion Cycle	60	27	53	22	17	21	29	15	25
Working Capital Days	90	83	99	96	107	20	8	16	18
ROCE %		11%	18%	24%	11%	5%	13%	11%	-4%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	46.28%	46.28%	46.28%	46.28%	46.28%	46.28%	46.28%	46.28%	46.28%	46.28%	46.28%	46.28%
FIIs	1.82%	2.05%	1.98%	2.07%	2.07%	1.98%	1.88%	2.07%	2.10%	1.92%	1.94%	1.79%
DIIs	1.68%	1.63%	1.47%	1.45%	1.51%	1.51%	1.96%	2.17%	3.13%	3.46%	3.76%	4.14%
Public	50.22%	50.04%	50.27%	50.19%	50.13%	50.22%	49.88%	49.49%	48.48%	48.34%	48.01%	47.79%
No. of Shareholders	77,773	87,428	87,083	85,354	84,097	85,393	88,020	86,698	82,719	79,560	78,681	75,697

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
ICICI Prudential Regular Savings Fund	75,047	0.18	5.96	75,047	2025-04-22 17:25:34	0%
Motilal Oswal Nifty Microcap 250 Index Fund	31,263	0.18	2.48	31,263	2025-04-22 17:25:34	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	-32.25	55.78	76.22	22.57	45.22
Diluted EPS (Rs.)	-32.25	55.78	76.22	22.57	45.22
Cash EPS (Rs.)	33.38	115.99	103.46	46.46	67.36
Book Value[Excl.RevalReserv]/Share (Rs.)	827.30	835.97	803.30	731.86	625.79
Book Value[Incl.RevalReserv]/Share (Rs.)	827.30	835.97	803.30	731.86	625.79
Revenue From Operations / Share (Rs.)	518.34	615.01	511.82	330.82	371.00
PBDIT / Share (Rs.)	30.79	157.51	140.60	57.96	90.89
PBIT / Share (Rs.)	-20.60	119.92	113.67	34.21	68.86
PBT / Share (Rs.)	-26.67	117.27	112.83	32.11	66.94
Net Profit / Share (Rs.)	-18.01	78.39	76.52	22.72	45.32
NP After MI And SOA / Share (Rs.)	-32.25	55.78	76.22	22.57	45.22
PBDIT Margin (%)	5.93	25.61	27.47	17.51	24.49
PBIT Margin (%)	-3.97	19.49	22.20	10.34	18.55
PBT Margin (%)	-5.14	19.06	22.04	9.70	18.04
Net Profit Margin (%)	-3.47	12.74	14.95	6.86	12.21
NP After MI And SOA Margin (%)	-6.22	9.06	14.89	6.82	12.18
Return on Networth / Equity (%)	-3.89	6.67	9.48	3.08	7.22
Return on Capital Employeed (%)	-2.07	11.75	11.52	3.84	9.42
Return On Assets (%)	-2.95	4.91	7.01	2.31	5.63
Long Term Debt / Equity (X)	0.05	0.07	0.09	0.08	0.02
Total Debt / Equity (X)	0.08	0.09	0.10	0.08	0.03
Asset Turnover Ratio (%)	0.46	0.55	0.49	0.37	0.47
Current Ratio (X)	1.23	1.68	1.49	1.78	2.60
Quick Ratio (X)	0.67	1.13	1.01	1.41	2.15
Inventory Turnover Ratio (X)	6.75	6.45	6.97	6.16	6.40
Dividend Payout Ratio (NP) (%)	-73.02	17.92	10.49	35.44	17.69
Dividend Payout Ratio (CP) (%)	123.03	10.70	7.75	17.27	11.89
Earning Retention Ratio (%)	173.02	82.08	89.51	64.56	82.31
Cash Earning Retention Ratio (%)	-23.03	89.30	92.25	82.73	88.11
Interest Coverage Ratio (X)	5.07	59.43	168.00	27.53	47.54
Interest Coverage Ratio (Post Tax) (X)	-1.97	30.58	92.43	11.79	24.71
Enterprise Value (Cr.)	5324.43	4435.11	6873.06	2607.27	1735.82
EV / Net Operating Revenue (X)	1.40	0.98	1.83	1.07	0.63
EV / EBITDA (X)	23.55	3.83	6.66	6.13	2.60
MarketCap / Net Operating Revenue (X)	1.30	0.95	1.75	1.04	0.60
Retention Ratios (%)	173.02	82.07	89.50	64.55	82.30
Price / BV (X)	0.81	0.70	1.12	0.47	0.35
Price / Net Operating Revenue (X)	1.30	0.95	1.75	1.04	0.60
EarningsYield	-0.04	0.09	0.08	0.06	0.20

After reviewing the key financial ratios for Gujarat Alkalies & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is -32.25. This value is below the healthy minimum of 5. It has decreased from 55.78 (Mar 23) to -32.25, marking a decrease of 88.03.
For Diluted EPS (Rs.), as of Mar 24, the value is -32.25. This value is below the healthy minimum of 5. It has decreased from 55.78 (Mar 23) to -32.25, marking a decrease of 88.03.
For Cash EPS (Rs.), as of Mar 24, the value is 33.38. This value is within the healthy range. It has decreased from 115.99 (Mar 23) to 33.38, marking a decrease of 82.61.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 827.30. It has decreased from 835.97 (Mar 23) to 827.30, marking a decrease of 8.67.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 827.30. It has decreased from 835.97 (Mar 23) to 827.30, marking a decrease of 8.67.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 518.34. It has decreased from 615.01 (Mar 23) to 518.34, marking a decrease of 96.67.
For PBDIT / Share (Rs.), as of Mar 24, the value is 30.79. This value is within the healthy range. It has decreased from 157.51 (Mar 23) to 30.79, marking a decrease of 126.72.
For PBIT / Share (Rs.), as of Mar 24, the value is -20.60. This value is below the healthy minimum of 0. It has decreased from 119.92 (Mar 23) to -20.60, marking a decrease of 140.52.
For PBT / Share (Rs.), as of Mar 24, the value is -26.67. This value is below the healthy minimum of 0. It has decreased from 117.27 (Mar 23) to -26.67, marking a decrease of 143.94.
For Net Profit / Share (Rs.), as of Mar 24, the value is -18.01. This value is below the healthy minimum of 2. It has decreased from 78.39 (Mar 23) to -18.01, marking a decrease of 96.40.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -32.25. This value is below the healthy minimum of 2. It has decreased from 55.78 (Mar 23) to -32.25, marking a decrease of 88.03.
For PBDIT Margin (%), as of Mar 24, the value is 5.93. This value is below the healthy minimum of 10. It has decreased from 25.61 (Mar 23) to 5.93, marking a decrease of 19.68.
For PBIT Margin (%), as of Mar 24, the value is -3.97. This value is below the healthy minimum of 10. It has decreased from 19.49 (Mar 23) to -3.97, marking a decrease of 23.46.
For PBT Margin (%), as of Mar 24, the value is -5.14. This value is below the healthy minimum of 10. It has decreased from 19.06 (Mar 23) to -5.14, marking a decrease of 24.20.
For Net Profit Margin (%), as of Mar 24, the value is -3.47. This value is below the healthy minimum of 5. It has decreased from 12.74 (Mar 23) to -3.47, marking a decrease of 16.21.
For NP After MI And SOA Margin (%), as of Mar 24, the value is -6.22. This value is below the healthy minimum of 8. It has decreased from 9.06 (Mar 23) to -6.22, marking a decrease of 15.28.
For Return on Networth / Equity (%), as of Mar 24, the value is -3.89. This value is below the healthy minimum of 15. It has decreased from 6.67 (Mar 23) to -3.89, marking a decrease of 10.56.
For Return on Capital Employeed (%), as of Mar 24, the value is -2.07. This value is below the healthy minimum of 10. It has decreased from 11.75 (Mar 23) to -2.07, marking a decrease of 13.82.
For Return On Assets (%), as of Mar 24, the value is -2.95. This value is below the healthy minimum of 5. It has decreased from 4.91 (Mar 23) to -2.95, marking a decrease of 7.86.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.07 (Mar 23) to 0.05, marking a decrease of 0.02.
For Total Debt / Equity (X), as of Mar 24, the value is 0.08. This value is within the healthy range. It has decreased from 0.09 (Mar 23) to 0.08, marking a decrease of 0.01.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.46. It has decreased from 0.55 (Mar 23) to 0.46, marking a decrease of 0.09.
For Current Ratio (X), as of Mar 24, the value is 1.23. This value is below the healthy minimum of 1.5. It has decreased from 1.68 (Mar 23) to 1.23, marking a decrease of 0.45.
For Quick Ratio (X), as of Mar 24, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 1.13 (Mar 23) to 0.67, marking a decrease of 0.46.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 6.75. This value is within the healthy range. It has increased from 6.45 (Mar 23) to 6.75, marking an increase of 0.30.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is -73.02. This value is below the healthy minimum of 20. It has decreased from 17.92 (Mar 23) to -73.02, marking a decrease of 90.94.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 123.03. This value exceeds the healthy maximum of 50. It has increased from 10.70 (Mar 23) to 123.03, marking an increase of 112.33.
For Earning Retention Ratio (%), as of Mar 24, the value is 173.02. This value exceeds the healthy maximum of 70. It has increased from 82.08 (Mar 23) to 173.02, marking an increase of 90.94.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is -23.03. This value is below the healthy minimum of 40. It has decreased from 89.30 (Mar 23) to -23.03, marking a decrease of 112.33.
For Interest Coverage Ratio (X), as of Mar 24, the value is 5.07. This value is within the healthy range. It has decreased from 59.43 (Mar 23) to 5.07, marking a decrease of 54.36.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -1.97. This value is below the healthy minimum of 3. It has decreased from 30.58 (Mar 23) to -1.97, marking a decrease of 32.55.
For Enterprise Value (Cr.), as of Mar 24, the value is 5,324.43. It has increased from 4,435.11 (Mar 23) to 5,324.43, marking an increase of 889.32.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.40. This value is within the healthy range. It has increased from 0.98 (Mar 23) to 1.40, marking an increase of 0.42.
For EV / EBITDA (X), as of Mar 24, the value is 23.55. This value exceeds the healthy maximum of 15. It has increased from 3.83 (Mar 23) to 23.55, marking an increase of 19.72.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has increased from 0.95 (Mar 23) to 1.30, marking an increase of 0.35.
For Retention Ratios (%), as of Mar 24, the value is 173.02. This value exceeds the healthy maximum of 70. It has increased from 82.07 (Mar 23) to 173.02, marking an increase of 90.95.
For Price / BV (X), as of Mar 24, the value is 0.81. This value is below the healthy minimum of 1. It has increased from 0.70 (Mar 23) to 0.81, marking an increase of 0.11.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has increased from 0.95 (Mar 23) to 1.30, marking an increase of 0.35.
For EarningsYield, as of Mar 24, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 23) to -0.04, marking a decrease of 0.13.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Gujarat Alkalies & Chemicals Ltd as of April 28, 2025 is: 399.88

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 28, 2025, Gujarat Alkalies & Chemicals Ltd is Overvalued by 35.81% compared to the current share price 623.00

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of Gujarat Alkalies & Chemicals Ltd as of April 28, 2025 is: 191.28

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 28, 2025, Gujarat Alkalies & Chemicals Ltd is Overvalued by 69.30% compared to the current share price 623.00

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: -52.17%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (4,793.50 cr) compared to borrowings (422.70 cr), indicating strong financial stability. The company has shown consistent growth in sales (2.50 cr) and profit (315.60 cr) over the years.	The stock has a low average ROCE of 9.89%, which may not be favorable. The stock has a high average Working Capital Days of 59.67, which may not be favorable. The stock has a high average Cash Conversion Cycle of 29.89, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gujarat Alkalies & Chemicals Ltd:
1. Net Profit Margin: -3.47%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: -2.07% (Industry Average ROCE: 9.52%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: -3.89% (Industry Average ROE: 6.89%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): -1.97
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.67
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 0 (Industry average Stock P/E: 64)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.08
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Gujarat Alkalies & Chemicals Ltd. is a Public Limited Listed company incorporated on 29/03/1973 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24110GJ1973PLC002247 and registration number is 002247. Currently Company is involved in the business activities of Manufacture of basic chemicals, fertilizer and nitrogen compounds, plastics and synthetic rubber in primary forms. Company's Total Operating Revenue is Rs. 3806.63 Cr. and Equity Capital is Rs. 73.44 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Inorganic - Caustic Soda/Soda Ash	P.O.: Ranoli Vadodra District Gujarat 391350	investor_relations@gacl.co.in http://www.gacl.com

Management
Name	Position Held
Dr. Hasmukh Adhia	Chairman
Mr. P Swaroop	Managing Director
Mr. Rajiv Lochan Jain	Independent Director
Mr. Nitin Shukla	Independent Director
Mr. Shridevi Shukla	Independent Director
Dr. Rahul Gupta	Director
Mr. Bimal Julka	Independent Director
Dr. Chinmay Ghoroi	Independent Director

FAQ

What is the intrinsic value of Gujarat Alkalies & Chemicals Ltd?

Gujarat Alkalies & Chemicals Ltd's intrinsic value (as of 27 April 2025) is ₹399.88 — 35.81% lower the current market price of 623.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4,575 Cr. market cap, FY2025-2026 high/low of ₹900/484, reserves of 6,112 Cr, and liabilities of 8,413 Cr.

What is the Market Cap of Gujarat Alkalies & Chemicals Ltd?

The Market Cap of Gujarat Alkalies & Chemicals Ltd is 4,575 Cr..

What is the current Stock Price of Gujarat Alkalies & Chemicals Ltd as on 27 April 2025?

The current stock price of Gujarat Alkalies & Chemicals Ltd as on 27 April 2025 is 623.

What is the High / Low of Gujarat Alkalies & Chemicals Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Gujarat Alkalies & Chemicals Ltd stocks is ₹900/484.

What is the Stock P/E of Gujarat Alkalies & Chemicals Ltd?

The Stock P/E of Gujarat Alkalies & Chemicals Ltd is .

What is the Book Value of Gujarat Alkalies & Chemicals Ltd?

The Book Value of Gujarat Alkalies & Chemicals Ltd is 842.

What is the Dividend Yield of Gujarat Alkalies & Chemicals Ltd?

The Dividend Yield of Gujarat Alkalies & Chemicals Ltd is 0.00 %.

What is the ROCE of Gujarat Alkalies & Chemicals Ltd?

The ROCE of Gujarat Alkalies & Chemicals Ltd is 3.83 %.

What is the ROE of Gujarat Alkalies & Chemicals Ltd?

The ROE of Gujarat Alkalies & Chemicals Ltd is 3.88 %.

What is the Face Value of Gujarat Alkalies & Chemicals Ltd?

The Face Value of Gujarat Alkalies & Chemicals Ltd is 10.0.